##  [News](/in-en/news "News") 

  [ 

 ![office-meeting](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2022-07/2610_300dpi_RGB.jpg.webp?itok=YJ2cA68F "office-meeting") 

 

###  News Archive 

News and more from the frontiers of medicine

 

 

 ](/in-en/news/news-archive) [ 

 ![Woman smiling and talking with a colleague](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2021-12/women-smiling-and-talking.jpg.webp?itok=Z0rIO1Ok "Woman smiling and talking with a colleague") 

 

###  Media contacts 

Find contacts at Novartis for media and journalist inquiries from the general and individual contacts.

 

 

 ](/in-en/news/media-contacts) [ 

 ![lung-cancer-hero-image](/in-en/sites/novartis_in/files/styles/cards_1_3/public/2021-07/lung-cancer-hero-image.jpg.webp?itok=nRlPLTDa "lung-cancer-hero-image") 

 

###  Stories 

Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.

 

 

 ](https://www.novartis.com/news/stories) 





 

 

 



##  Declaration 

In line with the recent GST change announced by the Government of India, Novartis Healthcare Private Limited have revised the medicine prices with the lower GST rates. The revised prices have been implemented with effect from 22/9/25, reflecting our commitment to comply with government regulations and to making treatments more affordable for patients. Novartis has also conveyed the revised prices to its CFA’s and stockiest with a request to intimate the same to retailers so that the same can be implemented immediately and pass the benefit of reduced prices to the patients.